Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 16, Issue 5, Pages 719-727
Publisher
Oxford University Press (OUP)
Online
2014-01-25
DOI
10.1093/neuonc/not316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma
- (2013) C.-K. Park et al. NEURO-ONCOLOGY
- The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer
- (2012) Jatinder Goyal et al. BJU INTERNATIONAL
- Pathological findings and prognostic factors in recurrent glioblastomas
- (2012) Yoshiko Okita et al. Brain Tumor Pathology
- Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
- (2012) Andreas M. Stark et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme
- (2012) Pål A. Rønning et al. NEURO-ONCOLOGY
- Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
- (2012) M. Weller et al. NEURO-ONCOLOGY
- Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis
- (2011) Robert A. Olson et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
- (2011) J. L. Clarke et al. NEURO-ONCOLOGY
- Radiochemotherapy with temozolomide for patients with glioblastoma
- (2011) Johanna Gerstein et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
- (2010) R. Helseth et al. ACTA NEUROLOGICA SCANDINAVICA
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
- (2010) John K. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
- (2010) Raffaele Addeo et al. JOURNAL OF NEURO-ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
- (2009) J. A. B. van Genugten et al. JOURNAL OF NEURO-ONCOLOGY
- ‘Recurrent’ glioblastoma multiforme, when should we reoperate?
- (2008) Giuseppe M. V. Barbagallo et al. BRITISH JOURNAL OF NEUROSURGERY
- Randomized Clinical Trials and Observational Studies
- (2008) Edward L. Hannan JACC-Cardiovascular Interventions
- Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival
- (2008) Mehul Patel et al. JOURNAL OF NEURO-ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
- (2007) Thierry Gorlia et al. LANCET ONCOLOGY
- Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
- (2007) Graziella Filippini et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started